#METABOLOMICS WORKBENCH jgengatharan_20240802_082301 DATATRACK_ID:5076 STUDY_ID:ST003381 ANALYSIS_ID:AN005539 PROJECT_ID:PR002085
VERSION             	1
CREATED_ON             	August 2, 2024, 8:42 am
#PROJECT
PR:PROJECT_TITLE                 	Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to
PR:PROJECT_TITLE                 	trans fat-induced atherosclerosis
PR:PROJECT_SUMMARY               	The goal of the project is to determine the role of sphingolipid metabolism in
PR:PROJECT_SUMMARY               	atherosclerosis induced by dietary trans fat. We analyzed lipid metabolites in
PR:PROJECT_SUMMARY               	Huh7 cells following various fatty acid treatments, with specific focus on cis
PR:PROJECT_SUMMARY               	and trans unsaturated fatty acids. Additionally, we analyzed lipid metabolites
PR:PROJECT_SUMMARY               	in plasma and liver of Ldlr-/- mice fed high-fat diets enriched in cis or trans
PR:PROJECT_SUMMARY               	fatty acids in the presence or absence of myriocin, a pharmacological inhibitor
PR:PROJECT_SUMMARY               	of SPT, the initial rate-limiting enzyme of sphingolipid biosynthesis.
PR:INSTITUTE                     	Salk Institute for Biological Studies
PR:LAST_NAME                     	Gengatharan
PR:FIRST_NAME                    	Jivani
PR:ADDRESS                       	10010 N Torrey Pines Rd, La Jolla, CA, 92037, USA
PR:EMAIL                         	jivani14@gmail.com
PR:PHONE                         	(858) 453-4100
#STUDY
ST:STUDY_TITLE                   	Impact of high-fat diet enriched in cis or trans fatty acids and myriocin on
ST:STUDY_TITLE                   	newly synthesized sphingolipids from D2O in circulation in Ldlr-/- mice
ST:STUDY_SUMMARY                 	We analyzed newly synthesized DHCer, Cer, and SM in plasma of Ldlr-/- mice fed
ST:STUDY_SUMMARY                 	1) Cis HFD, 2) Cis HFD + Myriocin, 3) Trans HFD, or 4) Trans HFD + Myriocin. We
ST:STUDY_SUMMARY                 	aimed to determine how dietary cis and trans monounsaturated fatty acids impact
ST:STUDY_SUMMARY                 	hepatic secretion of newly synthesized sphingolipids into circulation while
ST:STUDY_SUMMARY                 	pharmacologically inhibiting the initial rate-limiting enzyme of sphingolipid
ST:STUDY_SUMMARY                 	biosynthesis, serine palmitoyltransferase (SPT), via myriocin.
ST:INSTITUTE                     	Salk Institute for Biological Studies
ST:LAST_NAME                     	Gengatharan
ST:FIRST_NAME                    	Jivani
ST:ADDRESS                       	10010 N Torrey Pines Rd, La Jolla, CA, 92037, USA
ST:EMAIL                         	jivani14@gmail.com
ST:PHONE                         	(858) 453-4100
#SUBJECT
SU:SUBJECT_TYPE                  	Mammal
SU:SUBJECT_SPECIES               	Mus musculus
SU:TAXONOMY_ID                   	10090
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFD_71	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFD_71.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFD_72	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFD_72.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFD_73	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFD_73.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFD_74	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFD_74.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFD_75	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFD_75.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFDMyr_111	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFDMyr_111.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFDMyr_112	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFDMyr_112.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFDMyr_113	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFDMyr_113.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFDMyr_114	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFDMyr_114.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFDMyr_115	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFDMyr_115.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFD_21	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFD_21.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFD_22	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFD_22.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFD_23	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFD_23.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFD_24	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFD_24.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFD_25	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFD_25.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFDMyr_51	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFDMyr_51.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFDMyr_52	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFDMyr_52.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFDMyr_53	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFDMyr_53.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFDMyr_54	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFDMyr_54.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFDMyr_55	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFDMyr_55.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_CisHFD_152_MS2_top12	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_CisHFD_152_MS2_top12.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFD_22_MS2_top12	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFD_22_MS2_top12.mzXML
SUBJECT_SAMPLE_FACTORS           	-	PlasmaD2O_TransHFDMyr_52_MS2_top12	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	RAW_FILE_NAME(Raw file name)=PlasmaD2O_TransHFDMyr_52_MS2_top12.mzXML
#COLLECTION
CO:COLLECTION_SUMMARY            	Blood was collected in EDTA-coated tubes (Sarstedt Inc.) and centrifuged at
CO:COLLECTION_SUMMARY            	2000g for 5 min. The plasma supernatant was transferred to a new Eppendorf tube
CO:COLLECTION_SUMMARY            	and stored at -80°C until analysis.
CO:SAMPLE_TYPE                   	Liver
#TREATMENT
TR:TREATMENT_SUMMARY             	Four-five-week-old Ldlr-/- C57BL/6J male and female mice (JAX# 002207) were fed
TR:TREATMENT_SUMMARY             	with irradiated 60% high fat diets (HFD) prepared by Dyets for 16 weeks. These
TR:TREATMENT_SUMMARY             	diets include Cis Unsaturated HFD (105063GI), Cis Unsaturated HFD with 2.2 mg/kg
TR:TREATMENT_SUMMARY             	Myriocin Added (105064GI), Trans Unsaturated HFD (105061GI), and Trans
TR:TREATMENT_SUMMARY             	Unsaturated HFD with 2.2 mg/kg Myriocin Added (105061GI). The Trans Unsaturated
TR:TREATMENT_SUMMARY             	HFD was designed with 100% Primex, a partially hydrogenated vegetable oil, and
TR:TREATMENT_SUMMARY             	the Cis Unsaturated HFD was designed with 34% lard and 66% olive oil. Following
TR:TREATMENT_SUMMARY             	16 weeks of diet administration, mice were administered D2O in 0.9% NaCl at a
TR:TREATMENT_SUMMARY             	dose of 0.027 mL/g body weight via intraperitoneal injection. Drinking water was
TR:TREATMENT_SUMMARY             	replaced with 8% D2O drinking water for 30 hours. 24 hours post-injection, mice
TR:TREATMENT_SUMMARY             	were fasted for 6 hours with 8% D2O drinking water provided ad libitum. Blood
TR:TREATMENT_SUMMARY             	were collected as described above.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Sphingolipid biosynthesis via 2H2O enrichment in plasma was quantified by
SP:SAMPLEPREP_SUMMARY            	spiking 10 µL of plasma with internal standards 100 pmol d18:0-d7/13:0
SP:SAMPLEPREP_SUMMARY            	dihydroceramide (Avanti Polar Lipids, Cat# 330726), 200 pmol d18:1-d7/15:0
SP:SAMPLEPREP_SUMMARY            	ceramide (Avanti Polar Lipids, Cat# 860681), and 1 ug 15:0-18:1(d7)
SP:SAMPLEPREP_SUMMARY            	phosphatidylcholine (Avanti Polar Lipids, Cat #791637). 0.5 mL methanol, 0.5 mL
SP:SAMPLEPREP_SUMMARY            	H2O, and 1 mL chloroform were added directly. Samples were vortexed for 5 min,
SP:SAMPLEPREP_SUMMARY            	centrifuged for 5 min at 4 ˚C at 15,000g. The organic phase was collected and 2
SP:SAMPLEPREP_SUMMARY            	μL of formic acid was added to the remaining polar phase which was re-extracted
SP:SAMPLEPREP_SUMMARY            	with 1 mL of chloroform. Combined organic phases were dried under nitrogen.
SP:SAMPLEPREP_SUMMARY            	After dried extracts for plasma were resuspended in 60 µl MeOH, 5 µL of sample
SP:SAMPLEPREP_SUMMARY            	was injected.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Thermo Vanquish
CH:COLUMN_NAME                   	Phenomenex Kinetex C18 (100 x 2.1mm,1.7um)
CH:SOLVENT_A                     	98% water, 2% methanol; 5 mM ammonium acetate
CH:SOLVENT_B                     	50% methanol, 50% isopropanol; 5 mM ammonium acetate
CH:FLOW_GRADIENT                 	0 min, 30%B; 1 min, 30%B; 2 min, 70%B; 11 min, 95%B; 17 min, 30%B; 21.5 min,
CH:FLOW_GRADIENT                 	30%B; 27 min, 30%B.
CH:FLOW_RATE                     	0.2 mL/min
CH:COLUMN_TEMPERATURE            	35˚C
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Thermo Q Exactive Orbitrap
MS:INSTRUMENT_TYPE               	Orbitrap
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	Lipids were identified in EL-MAVEN using exact mass of precursor ion in MS1
MS:MS_COMMENTS                   	chromatogram and product ion in MS2 spectra. Lipids were quantified using peak
MS:MS_COMMENTS                   	areas in MS1 chromatogram. Relative abundance of lipids was calculated by
MS:MS_COMMENTS                   	normalizing to internal standard specific to lipid class and volume of plasma.
MS:MS_COMMENTS                   	Sphingomyelin was normalized to 15:0-18:1(d7) phosphatidylcholine as a
MS:MS_COMMENTS                   	deuterated sphingomyelin standard would have interfered with the mass
MS:MS_COMMENTS                   	isotopologue distribution of specific sphingomyelin species. The percent
MS:MS_COMMENTS                   	isotopologue distribution of each sphingolipid was determined and corrected for
MS:MS_COMMENTS                   	natural 13C abundance, the most abundant natural stable isotope, using in-house
MS:MS_COMMENTS                   	algorithms adapted from a previous report.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	Peak area
MS_METABOLITE_DATA_START
Samples	PlasmaD2O_CisHFD_71	PlasmaD2O_CisHFD_72	PlasmaD2O_CisHFD_73	PlasmaD2O_CisHFD_74	PlasmaD2O_CisHFD_75	PlasmaD2O_CisHFDMyr_111	PlasmaD2O_CisHFDMyr_112	PlasmaD2O_CisHFDMyr_113	PlasmaD2O_CisHFDMyr_114	PlasmaD2O_CisHFDMyr_115	PlasmaD2O_TransHFD_21	PlasmaD2O_TransHFD_22	PlasmaD2O_TransHFD_23	PlasmaD2O_TransHFD_24	PlasmaD2O_TransHFD_25	PlasmaD2O_TransHFDMyr_51	PlasmaD2O_TransHFDMyr_52	PlasmaD2O_TransHFDMyr_53	PlasmaD2O_TransHFDMyr_54	PlasmaD2O_TransHFDMyr_55	PlasmaD2O_CisHFD_152_MS2_top12	PlasmaD2O_TransHFD_22_MS2_top12	PlasmaD2O_TransHFDMyr_52_MS2_top12
Factors	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD + Myriocin D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD + Myriocin D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD + Myriocin D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD + Myriocin D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD + Myriocin D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Cis HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD D2O	Genotype:Ldlr-/- | Sample source:Mouse plasma | Group:Trans HFD + Myriocin D2O
Cer d18:1-d7/15:0	496445120	482349632	466657728	453763584	520661088	556293056	501928736	478491584	503235424	534039136	373103232	409527488	450920512	444880672	428421920	435417952	432429856	498536672	464792384	448135872			
Cer d18:1/22:0	312827732.9	496547103.7	322593831.5	366552921.3	374697533.9	28992673.88	105255472.7	91223989.59	105972412	126973438.3	651415526	540431680.3	512077076.3	498620987.3	526570901.2	80381078.52	143042742.5	87666094.74	127003893.8	91575345.59			
Cer d18:1/23:0	174573239.6	202229788.9	90765466.62	155350398.7	156300336.3	21009134.3	26843421.7	23810171.5	28225589.13	34477901.58	256135829.8	261288713.7	183451890.8	183482039.5	262404527.7	31944739.55	65508539.87	36063926.47	49736719.52	37696075			
Cer d18:1/24:0	399474615.6	443665840.4	253417287.3	305894789.5	381307435.8	53139104.57	70145240.31	75150917.12	79932782.82	89847526.37	679902998.8	590684654.6	460297710.5	446846923.4	615559109.8	90318902.31	157645406.5	99848065.43	130276351.4	92093749.33			
Cer d18:1/24:1	513190915.2	637322050.7	254309321.5	443336043	427959563.4	48974972.69	88707806.53	98508448.5	104380286.4	137065691.2	714895217.6	615014963.3	403825203	319725132.4	570563504.7	63651930.79	97603924.93	62818242.1	78960137	79904324.78			
DHCer d18:0-d7/13:0	639827200	616258688	556897408	521157536	651127808	610138304	608522304	564407616	600361024	667294848	574244672	589194944	617347200	644891520	600315520	605427712	623050624	715887872	658204992	578097600			
DHCer d18:0/22:0	214465481.6	149422865.9	66151604.82	104756704.5	139113990	29070947.1	18234154.9	13557075.53	21682114.81	25683253.53	257376457.5	222698418	203888942.5	230442392.3	228676227.4	28272785.88	58543550.93	31995868.43	38289450.71	36196593.33			
DHCer d18:0/23:0	189915391.4	114954268.7	52129235.71	74145002.51	130757175.6	20686876.17	8034703.21	7631007.28	9211976.59	10942418.07	146629648.2	147753835	125008781.9	172774803.3	144248704.7	20392279.65	35843149.11	22860712.13	24352064.67	20287927.69			
DHCer d18:0/24:0	251931540.2	153714230	66582719.69	88187871.36	178362196.3	28877089.77	11979835.41	11549910.66	14531638.07	15354691.69	220826724.9	185481670.8	184624547.3	240273594.6	202673767.2	30558501.25	51100142.9	30328511.34	35805581.18	28140886.6			
DHCer d18:0/24:1	86023147.5	96577033	29456496.9	59957321.7	74700491.41	10432625	11522312.76	10133768.97	15161024.44	17211913.17	138493580.6	81174342.64	59429144.91	43659393.41	84935838.03	7212463.62	16882459.17	9889061.77	10937727.29	8578733.87			
PC 15:0/18:1-d7	3424525312	3191621376	3564247296	3254399232	3540174848	5359330816	4044787200	3977310720	3996068352	4282804480	2207108864	2545928960	2966024960	2911051264	2706253824	3202237952	2984314368	3488564224	3424811776	3403724032			
SM d32:1	740389996.7	590930502.1	392892247.8	536650374.6	763893907.9	297909424.4	361182720.3	411906944.4	381234562.9	439056436.3	549622752.4	558926902.4	490601867.4	582857474	553473942.5	455343196.8	623125513.6	417956690	540767448.1	422362703.4			
SM d34:0	1384367669	1186894272	644635107.8	927646941.1	1117958011	539380718.3	431022803.8	441485644.6	479863714.4	532751431.5	1071935758	884073842.8	810642252.9	806837867.3	906321834.5	464754962.2	602343859.1	456052919	540645843.4	474055123.4			
SM d34:1	21030625166	22358875504	13715827586	17725714162	20415397135	9937839933	9528626984	10733552128	11400972825	10821475670	20550394720	18686203104	16640525717	16554313412	19259788738	10692034564	12625012780	10251721971	11957154338	10551220539			
SM d34:2	2894643463	3452898032	2334615110	2979011270	3529387880	734858460	2183809531	2313116164	2440120861	2584883939	3447311228	3387860709	3196233077	3556194891	3782942546	2532127216	3305594540	2526744023	3077860261	2553707474			
SM d34:3	8010688.03	11702382.5	9230514.5	10584568.25	14946602.5	1609917.88	5285573.86	8525555	8748784.75	8914749.5	75496424	80291792.12	86197348.43	91282818	84406850	67775233.6	94430575.64	73223202	82475068	71853436			
SM d36:1	2647414880	2845616723	1641930194	2317294036	2358320639	1812298942	1297520256	1455015554	1398170788	1642825839	1595277154	1359493244	1147147632	1109286141	1398802750	881647434.8	1023416821	729693429.9	968261749.1	873382984			
SM d36:2	1390661769	1549007508	1081487936	1361128815	1490281268	680281440	865242672	955215003.2	991943047.2	1043169342	3935750108	4017029973	3745842547	3430809209	4074876275	2836581268	3370473153	2835635424	3082979119	2835230672			
SM d36:3	165818021	199138848	114798780.5	162800475.8	181789776	37905674	84802008.77	92932353.01	100831572.9	100701643	809146240	827511208	836731536.5	827973844	807184812	638709320	715670172.3	613391264	746053836	386450880			
SM d38:1	1700060215	2361423959	1855961369	2138747178	2065964366	562747408	1080079188	1096656551	1124868555	1250826931	1946682224	1609625870	1824450472	1714585272	1674198321	750070205.5	1070801705	753305798	1108824292	755829598.6			
SM d38:2	266865994.5	333843617.5	289815203	345517467.6	347286465.8	128001071	222813368	261614468.5	258527608.4	270514574.9	630396272	779670240	915457136.5	902635984	775189726.5	484724980	632445760	490589588	657065507.4	501480408.4			
SM d38:3	23872046.62	30159348.44	15326599	26114547	28564026.5	10016335.62	13682051	15543388.5	15145877.04	19732238.69	100205884.5	144354897	177386278	174078970	146706097.3	118545360	168013152	132722075	179221460	133136783			
SM d40:1	6190927902	8278989749	9582385558	7448982137	8100069678	1550071685	5499819619	4891198508	5744854919	5659645881	9293387933	8314384144	11027577135	9710791857	8591906939	3409807100	4659114074	3526380624	5299359705	3370018026			
SM d40:2	3065095327	3522867700	3573275762	3543605936	3616723961	588548296.7	2195689020	2331607399	2191795648	2352910592	5856387384	5791387868	8569568788	7723104796	5803197610	2883237380	4126356078	3006757294	4139711720	3148490567			
SM d40:3	141069048	177646460.4	193668431.2	202266150	200084094.6	62176906.09	156970992.5	173562776	158725535.5	181198010	300161348	381570624	565299232	532379960	372107868	320796136	398860832	339174948	444959192	381146984			
SM d42:1	4157522908	5338085923	3665286746	3739067772	4539649389	764962552	1588668232	1727591360	1706240285	1683787690	5647896212	5137565832	5058453293	4820709734	5175562461	1778167129	2341324764	1805781040	2500937517	1476661291			
SM d42:2	25251888220	24902511628	16112021584	19780002096	21436374792	7832761792	8668811951	9963790776	10399756842	10874135874	22637393200	17587225358	16617464276	13481352197	17920994244	6321540853	7959766016	6108302399	7503106824	6753592732			
SM d42:3	2890326112	3211163515	2536068704	3001030858	3095512615	1432275232	2103043642	2336371982	2331543611	2460254200	4279184044	3922941872	4275853308	3346239456	3918364140	1832957487	2187251500	1196625952	2240264412	2135384884			
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	m/z
Cer d18:1-d7/15:0	531.5477
Cer d18:1/22:0	622.613
Cer d18:1/23:0	636.6288
Cer d18:1/24:0	650.6443
Cer d18:1/24:1	648.629
DHCer d18:0-d7/13:0	505.5278
DHCer d18:0/22:0	624.6288
DHCer d18:0/23:0	638.6444
DHCer d18:0/24:0	652.6597
DHCer d18:0/24:1	650.6445
PC 15:0/18:1-d7	753.6151
SM d32:1	675.5434
SM d34:0	705.5893
SM d34:1	703.5742
SM d34:2	701.5585
SM d34:3	699.5431
SM d36:1	731.6054
SM d36:2	729.5897
SM d36:3	727.5748
SM d38:1	759.637
SM d38:2	757.6223
SM d38:3	755.6053
SM d40:1	787.6685
SM d40:2	785.6532
SM d40:3	783.6374
SM d42:1	815.6999
SM d42:2	813.6843
SM d42:3	811.6681
METABOLITES_END
#END